Harpoon Therapeutics Inc Quick Ratio (HARP) starting from the third quarter 2023 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Harpoon Therapeutics Inc   (NASDAQ: HARP)

Harpoon Therapeutics Inc 's Quick Ratio

HARP's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2023, Quick Ratio deteriorated to 1.75 below Harpoon Therapeutics Inc 's average Quick Ratio.

Within Medical Equipment & Supplies industry 103 other companies have achieved higher Quick Ratio than Harpoon Therapeutics Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 1397 to 1555.

Explain Quick Ratio?
How much Cash & cash equivalents HARP´s has?
What are HARP´s Current Liabilities?




HARP Quick Ratio (Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
Y / Y Current Liabilities Change -66.51 % -56.49 % -24.6 % -32.63 % -2.38 %
Y / Y Cash & cash equivalent Change -52.18 % -49.47 % -45.42 % -60.69 % -56.34 %
Quick Ratio MRQ 1.75 1.8 1.39 1.33 1.22
HARP's Total Ranking # 1555 # 1397 # 1566 # 0 # 1845
Seq. Current Liabilities Change -28.53 % -42.65 % 10.87 % -26.3 % -7.15 %
Seq. Cash & cash equivalent Change -30.62 % -25.79 % 15.58 % -19.65 % -26.68 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 104
Healthcare Sector # 657
Overall Market # 1555


Quick Ratio Statistics
High Average Low
14.64 4.64 1.22
(Dec 31 2019)   (Sep 30 2022)




Financial Statements
Harpoon Therapeutics Inc 's Current Liabilities $ 18 Millions Visit HARP's Balance sheet
Harpoon Therapeutics Inc 's Cash & cash equivalent $ 32 Millions Visit HARP's Balance sheet
Source of HARP's Sales Visit HARP's Sales by Geography


Cumulative Harpoon Therapeutics Inc 's Quick Ratio

HARP's Quick Ratio for the trailling 12 Months

HARP Quick Ratio

(Sep 30 2023)
12 Months
(Jun 30 2023)
12 Months
(Mar 31 2023)
12 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth -44.59 % -29.36 % -13.83 % -21.19 % -10.21 %
Y / Y Cash & cash equivalent TTM Growth -52.54 % -53.76 % -52.5 % -53.15 % -40.43 %
Quick Ratio TTM 1.5 1.38 1.38 1.53 1.76
Total Ranking TTM # 3859 # 1084 # 3849 # 0 # 1619
Seq. Current Liabilities TTM Growth -22 % -16.75 % -6.84 % -8.39 % -0.57 %
Seq. Cash & cash equivalent TTM Growth -15.25 % -16.47 % -15.87 % -20.3 % -17.44 %


On the trailing twelve months basis Current Liabilities decreased faster than Harpoon Therapeutics Inc 's average Cash & cash equivalent, this led to increase in in Harpoon Therapeutics Inc 's Quick Ratio to 1.5, Quick Ratio remained below HARP average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 215 other companies have achieved higher Quick Ratio than Harpoon Therapeutics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 1084 to 3859.

Explain Quick Ratio?
How much Cash & cash equivalents HARP´s has?
What are HARP´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 216
Healthcare Sector # 1057
Within the Market # 3859


trailing twelve months Quick Ratio Statistics
High Average Low
7.72 3.11 1.44
(Mar 31 2020)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2023, within Medical Equipment & Supplies Industry Quick RatioSep 30 2023 MRQ Cash & cash equivalentSep 30 2023 MRQ Current Liabilities
Glucotrack Inc   4.74 $ 6.888  Millions$ 1.454  Millions
Pulmonx Corporation  4.63 $ 94.945  Millions$ 20.485  Millions
Solana Company  4.60 $ 6.596  Millions$ 1.435  Millions
Glaukos Corp  4.48 $ 300.857  Millions$ 67.147  Millions
Skinhealth Systems Inc   4.44 $ 559.444  Millions$ 125.879  Millions
Clearpoint Neuro Inc   4.36 $ 24.342  Millions$ 5.589  Millions
Profound Medical Corp   4.12 $ 26.213  Millions$ 6.366  Millions
Dror Ortho-Design, Inc.  4.09 $ 4.016  Millions$ 0.981  Millions
Bone Biologics Corporation  4.04 $ 4.453  Millions$ 1.103  Millions
Sensus Healthcare Inc   3.92 $ 20.487  Millions$ 5.231  Millions
Intuitive Surgical Inc   3.86 $ 6,475.700  Millions$ 1,676.400  Millions
Tela Bio Inc   3.80 $ 58.202  Millions$ 15.334  Millions
Star Equity Holdings Inc   3.78 $ 25.561  Millions$ 6.761  Millions
Anika Therapeutics Inc   3.75 $ 105.333  Millions$ 28.064  Millions
Cutera Inc   3.73 $ 179.516  Millions$ 48.155  Millions
Treace Medical Concepts Inc   3.68 $ 122.163  Millions$ 33.154  Millions
Logicmark Inc  3.47 $ 6.683  Millions$ 1.927  Millions
Lemaitre Vascular Inc   3.34 $ 97.018  Millions$ 29.029  Millions
Vivani Medical Inc   3.34 $ 24.821  Millions$ 7.433  Millions
Nexalin Technology Inc   3.34 $ 3.937  Millions$ 1.179  Millions
Staar Surgical Co  3.31 $ 188.113  Millions$ 56.775  Millions
Zynex inc   3.17 $ 52.441  Millions$ 16.561  Millions
Beyond Air Inc   3.10 $ 38.642  Millions$ 12.454  Millions
Nephros Inc   3.05 $ 4.622  Millions$ 1.517  Millions
Icecure Medical Ltd  3.03 $ 11.062  Millions$ 3.648  Millions
Si bone inc   2.98 $ 53.492  Millions$ 17.969  Millions
Neuroone Medical Technologies Corp  2.97 $ 5.322  Millions$ 1.793  Millions
Delcath Systems Inc   2.90 $ 40.512  Millions$ 13.974  Millions
Inogen Inc   2.88 $ 138.040  Millions$ 48.009  Millions
Catheter Precision Inc   2.74 $ 5.579  Millions$ 2.035  Millions

Date modified: 2026-09-26T07:35:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.